Weiliang Zhu
wlzhu@simm.ac.cn
Chinese, English
Shanghai
University of Chinese Academy of Sciences
Medical School
  • 1995-09--1998-04 Ph.D.: Shanghai Institute of Materia Medica, Chinese Academy of Sciences
  • 1986-09--1988-07 Master's Degree: Department of Chemistry, Soochow University
  • 1979-09--1983-07 Bachelor's Degree: School of Chemistry and Chemical Engineering, Yangzhou University
  • 2009-04~Present - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Director of Drug Discovery and Design Center
  • 2004-07~Present - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Researcher, Doctoral Supervisor
  • 1998-05~2004-07 - Life Sciences and Technology Center, Singapore Polytechnic - Lecturer
  • 1989-08~1995-08 - Agricultural College, Yangzhou University - Assistant Lecturer, Lecturer
  • 1983-08~1986-08 - Agricultural College, Yangzhou University - Assistant Lecturer
Molecular Simulation and Drug Design
Medicinal Chemistry
  • Design and synthesis of cantharidin derivative DCZ5418 as a TRIP13 inhibitor with anti-multiple myeloma activity in vitro and in vivo, Sanfeng Dong, Ke Hu, Yulong Shi, Guanli Wang, Dandan Yu, Yitian Zhao, Hui Zhang, Yingcong Wang, Haiguo Sun, Zhijian Xu, Qi Jia, Yiming Li, Yingxia Li, Bo Li, Jumei Shi, Weiliang Zhu, 2024
  • Preferred microenvironments of halogen bonds and hydrogen bonds revealed using statistics and QM/MM calculation studies, Liping Zhou, Jintian Li, Yulong Shi, Leyun Wu, Weiliang Zhu, Zhijian Xu, 2023
  • Development of a Novel 18F-Labeled Probe for PET Imaging of Estrogen Receptor beta, Yujing Zhou, Peng Lei, Jiaxin Han, Zhiming Wang, Aiyan Ji, Yuyang Wu, Lingling Zheng, Xiaoqing Zhang, Chunrong Qu, Jian Min, Weiliang Zhu, Zhijian Xu, Xingdang Liu, Hao Chen, Zhen Cheng, 2023
  • Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma, Li Xu, Yingcong Wang, Guanli Wang, Shushan Guo, Dandan Yu, Qilin Feng, Ke Hu, Gege Chen, Bo Li, Zhijian Xu, Xinyan Jia, Yumeng Lu, Hui Zhang, Xuejie Gao, Shuaikang Chang, Huaping Wang, Xiaosong Wu, Dongliang Song, Guang Yang, Huabin Zhu, Jinfeng Zhou, Fenghuang Zhan, Weiliang Zhu, Jumei Shi, 2023
  • 红景天苷通过抑制TNF-α/NF-κB通路改善C2C12细胞萎缩的研究, 莉萍 陈, 艳蕾 张, 梦玲 马, 湘萍 康, 勇 张, 志建 徐, 维良 朱, 张斌 龚, 2023
Molecular Simulation Drug Design Computational Chemistry Pharmacophore Virtual Screening Protein-Ligand Interaction Binding Affinity Molecular Dynamics Structure-Based Drug Design Lead Optimization

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.